In October 2024, a widely shared podcast interview promoted microdosing as a "gamechanger." By late 2025, an Evidation survey found that roughly 14.6% of GLP-1 users, about 1 in 7, were microdosing
This condition typically affects the feet and legs first, progressing in a characteristic 'glove and stocking' distribution
The authors point to a key reason for the gap between trials and real life
SiddiqueMKatasHJamilAMohd AminMNgSZulfakarMet alPotential treatment of atopic dermatitis: Tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects
Combined with long travel days, restaurant meals, and changing schedules, it can become harder to meet your nutrition needs
Twenty-six weeks after randomization to tesamorelin, ALT decreased by 8.9 22.6 U/L among VAT responders, whereas it increased by 1.4 34.7 U/L among VAT nonresponders (responders vs